Luchun Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Luchun Xu has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Yongdong Yang
Department of Orthopedics, Dongzhimen Hospital, Beijing University of Chinese Medicine, China
3 shared publications - Guozheng Jiang
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
2 shared publications - Jiawei Song
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
2 shared publications - Ningning Feng
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
2 shared publications - Qing Kang
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
2 shared publications - Sixue Chen
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
2 shared publications
Latest Publications
- Open Access
- 5 June 2026
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 14, 1784592
Regulation of microglial polarization via notch signaling pathway by intrathecal administration of tanshinone IIA-PLGA sustained-release microspheres to promote neurological recovery after spinal cord injury
Secondary injuries following spinal cord injury (SCI) are closely associated with the activation of microglia and neuroinflammation. Tanshinone IIA (TIIA), a traditional Chinese medicine monomer with anti-inflammatory and antioxidant properties, has shown neuroprotective effects after SCI. Our previous studies indicated that TIIA exhibited inhibitory effects on early inflammatory responses and microglial activation after SCI, but its underlying mechanisms remained unclear. Due to TIIA’s poor water solubility and low bioavailability, its sulfonated derivative, sodium tanshinone IIA sulfonate (STS), was developed to address these issues. However, STS still faced challenges in crossing the blood-spinal cord barrier and exhibited poor stability. In this study, we utilized an emulsion electrospinning technique to load TIIA into poly (lactic-co-glycolic) acid (PLGA) microspheres, creating TIIA-loaded PLGA sustained-release microspheres (TIIA-PLGA SRMs). A single injection of an adequate amount of TIIA-PLGA SRMs was administered into the subarachnoid space through the atlanto-occipital membrane, and its regulatory effects on microglia after SCI were compared with a traditional continuous intraperitoneal injection of STS. Our experimental results demonstrated that intrathecal injection of TIIA-PLGA SRMs effectively promoted the transition of microglial phenotypes from M1 to M2 in the early stages in rats after SCI, alleviating neuroinflammation and improving motor dysfunction and neuropathic pain after SCI. Furthermore, the efficacy of TIIA-PLGA SRMs was superior to the traditional continuous intraperitoneal injection of STS. Additionally, our experiments suggested that the mechanism underlying TIIA-PLGA SRMs in regulating microglial polarization after SCI may be associated with the inhibition of the Notch signaling pathway.
- 5 June 2026
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 14, 1784592
Open AccessRegulation of microglial polarization via notch signaling pathway by intrathecal administration of tanshinone IIA-PLGA sustained-release microspheres to promote neurological recovery after spinal cord injury
Secondary injuries following spinal cord injury (SCI) are closely associated with the activation of microglia and neuroinflammation. Tanshinone IIA (TIIA), a traditional Chinese medicine monomer with anti-inflammatory and antioxidant properties, has shown neuroprotective effects after SCI. Our previous studies indicated that TIIA exhibited inhibitory effects on early inflammatory responses and microglial activation after SCI, but its underlying mechanisms remained unclear. Due to TIIA’s poor water solubility and low bioavailability, its sulfonated derivative, sodium tanshinone IIA sulfonate (STS), was developed to address these issues. However, STS still faced challenges in crossing the blood-spinal cord barrier and exhibited poor stability. In this study, we utilized an emulsion electrospinning technique to load TIIA into poly (lactic-co-glycolic) acid (PLGA) microspheres, creating TIIA-loaded PLGA sustained-release microspheres (TIIA-PLGA SRMs). A single injection of an adequate amount of TIIA-PLGA SRMs was administered into the subarachnoid space through the atlanto-occipital membrane, and its regulatory effects on microglia after SCI were compared with a traditional continuous intraperitoneal injection of STS. Our experimental results demonstrated that intrathecal injection of TIIA-PLGA SRMs effectively promoted the transition of microglial phenotypes from M1 to M2 in the early stages in rats after SCI, alleviating neuroinflammation and improving motor dysfunction and neuropathic pain after SCI. Furthermore, the efficacy of TIIA-PLGA SRMs was superior to the traditional continuous intraperitoneal injection of STS. Additionally, our experiments suggested that the mechanism underlying TIIA-PLGA SRMs in regulating microglial polarization after SCI may be associated with the inhibition of the Notch signaling pathway.
- 6 September 2025
- Published by Springer Nature in European Spine Journal
- p. 1-11
Comparison of 10-year follow-up result of hybrid surgery and anterior cervical discectomy and fusion for the treatment of contiguous three-level cervical degenerative disc diseases: risk factors for heterotopic ossification
- 6 September 2025
- Published by Springer Nature in European Spine Journal
- p. 1-11
Comparison of 10-year follow-up result of hybrid surgery and anterior cervical discectomy and fusion for the treatment of contiguous three-level cervical degenerative disc diseases: risk factors for heterotopic ossification
- 6 September 2025
- Published by Springer Nature in European Spine Journal
- p. 1-11
Comparison of 10-year follow-up result of hybrid surgery and anterior cervical discectomy and fusion for the treatment of contiguous three-level cervical degenerative disc diseases: risk factors for heterotopic ossification
- 6 September 2025
- Published by Springer Nature in European Spine Journal
- p. 1-11
Comparison of 10-year follow-up result of hybrid surgery and anterior cervical discectomy and fusion for the treatment of contiguous three-level cervical degenerative disc diseases: risk factors for heterotopic ossification